Table 1.
Clinical characteristics of patients
| Characteristics | All patients N(%) |
RT group N(%) |
Apatinib+RT group N(%) |
p |
|---|---|---|---|---|
| All patients | 63(100) | 31(100) | 32(100) | |
| Gender | ||||
| Female | 21 (33.3) | 15 (48.4) | 9 (28.1) | |
| Male | 42 (66.7) | 16 (51.6) | 23 (71.9) | 0.098 |
| Age | ||||
| <65 | 49 (77.8) | 24 (77.4) | 25 (78.1) | |
| ≥65 | 14 (22.2) | 7 (22.6) | 7 (21.9) | 0.946 |
| Smoking | ||||
| Never | 30 (47.6) | 19 (61.3) | 12 (37.5) | |
| Current/former | 33 (52.4) | 12 (38.7) | 20 (62.5) | 0.059 |
| KPS | ||||
| <70 | 18 (28.6) | 8 (25.8) | 10 (31.2) | |
| 70–100 | 45 (71.4) | 23 (74.2) | 22 (68.8) | 0.633 |
| Lung-molGPA | ||||
| 0–1.5 | 42 (66.7) | 22 (71.0) | 20 (62.5) | |
| 2–3 | 21 (33.3) | 9 (29.0) | 12 (37.5) | 0.476 |
| Histology | ||||
| Adenocarcinoma | 39 (61.9) | 22 (71.0) | 17 (53.1) | |
| Non-adenocarcinoma | 24 (38.1) | 9 (29.0) | 15 (46.9) | 0.145 |
| WBRT/SRS | ||||
| WBRT | 28 (44.4) | 16 (51.6) | 12 (37.5) | |
| SRS | 35 (55.6) | 15 (48.4) | 20 (62.5) | 0.260 |
Lung Cancer Using Molecular Markers: Lung-molGPA;Radiation RT: radiation therapy; Karnofsky Performance Status: KPS.